Skip to main content
    T

    Tenax Therapeutics Inc (TENX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.48
    -0.14 (-8.64%)

    Market Cap: $73.77M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    63%(25/40)
    Avg Surprise
    -4.99%
    Streak
    10 Q

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.36
    Range-$0.42 - -$0.21
    10 analysts
    Revenue Consensus
    N/A
    RangeN/A
    10 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.36
    Range-$0.42 - -$0.33
    3 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.38+5.3%
    60d ago-$0.39+7.7%
    30d ago-$0.39+7.7%
    7d ago-$0.39+7.7%
    Current-$0.36
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-1.60xFCF Yield-62.39%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-64.20%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio14.01xQuick Ratio14.01x
    Trading Statistics
    Beta0.97Avg Volume1.54M
    52-Week High$19.4052-Week Low$1.31

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 17.1% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 35.4, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.68
    SMA 20$1.71
    SMA 50$1.79
    SMA 200$9.35
    EMA 10$1.65
    EMA 20$1.71
    EMA 50$2.50
    EMA 200$6.98

    MACD

    Line: -0.10Signal: -0.11Hist: 0.01

    ADX

    ADX: 20.4+DI: 18.2-DI: 31.2

    Aroon & PSAR

    Aroon Up52.0
    Aroon Down16.0
    PSAR$2.01

    Bollinger Bands

    Upper Band$1.92
    Lower Band$1.51
    %B Position2374%(Upper)
    Band Width-0.07

    RSI (14-Day)

    Neutral
    35.4

    Momentum Oscillators

    Stoch %K10.2
    Stoch %D16.4
    Williams %R-95.5
    ROC (10d)-17.8%
    Momentum-0.32
    CCI (20d)-167.1
    MFI (14d)55.5

    Volatility Measures

    ATR (14d)$0.14(9.7%)
    StdDev (20d)0.10
    Hist Vol84.6%(High)

    Volume Flow

    VWAP$1.52
    OBV-15.6M
    AD Line-72.8M
    CMF (20d)-0.027

    Volume Metrics

    Avg Vol (20d)1.5M
    Vol Ratio0.7x
    VWMA (20d)$1.73

    Pivot Points

    R3$1.76
    R2$1.70
    R1$1.66
    Pivot Point$1.60
    S1$1.56
    S2$1.50
    S3$1.46

    Advanced Oscillators

    TSI-17.12
    Ultimate Osc47.6
    KST-21.84

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about TENX

    News

    TENX Valuation

    Tenax Therapeutics (TENX) trades at 0.3x forward earnings.

    Forward P/E
    0.3x
    P/FCF
    -1.6x
    P/B
    0.7x
    TENX valuation multiples

    TENX Profitability: Margins, ROIC and FCF

    Tenax Therapeutics (TENX) has an operating margin of 0.0% and a net margin of 0.0%.

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -64.2%
    FCF yield
    -62.4%
    TENX financial statements

    Tenax Therapeutics Competitors

    The companies most similar to Tenax Therapeutics (TENX) include Tenaya Therapeutics, Tonix Pharmaceuticals Holding and NRX Pharmaceuticals.

    Sector: Healthcare

    Companies most similar to Tenax Therapeutics

    TENX Analyst Ratings

    Tenax Therapeutics (TENX) has a Buy consensus from 10 analysts: 6 Buy or Strong Buy, 4 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    10
    Strong Buy
    1
    Buy
    5
    Hold
    4
    Sell
    0
    Strong Sell
    0
    TENX stock forecast

    TENX Bull Case vs Bear Case

    Bull case

    • TENX beat EPS estimates in 100.0% of its last 8 reported quarters.
    • 60.0% of TENX's analyst ratings are Buy or Strong Buy.

    TENX Earnings: Beat Rate and Next Report

    Tenax Therapeutics (TENX) beat the EPS estimate in 8 of the last 8 quarters (100.0%). Its next report is expected on Mar 8, 2027.

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    29.2%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.36
    TENX earnings history

    TENX Earnings Date

    TENX reports Mar 8, 2027. The date is estimated.

    See insider activity

    Updated Nov 7, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About TENX

    When does TENX report earnings?

    Tenax Therapeutics Inc (TENX) is expected to report earnings on Mar 8, 2027.

    Does TENX pay dividends?

    Tenax Therapeutics Inc (TENX) does not currently pay a regular dividend.

    What is TENX's market cap?

    Tenax Therapeutics Inc (TENX) has a market capitalization of $73.77M with a current stock price of $1.48.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.